{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T05:10:20Z","timestamp":1755925820726,"version":"3.44.0"},"reference-count":14,"publisher":"Tottori University Faculty of Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Yonago Acta Med."],"published-print":{"date-parts":[[2025]]},"DOI":"10.33160\/yam.2025.08.006","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T22:10:27Z","timestamp":1752099027000},"page":"275-279","source":"Crossref","is-referenced-by-count":0,"title":["Use of Gabapentin for Paroxysmal Sympathetic Hyperactivity in Three Children with Severe Motor and Intellectual Disability due to Neonatal Hypoxic Ischemic Encephalopathy"],"prefix":"10.33160","volume":"68","author":[{"given":"Go","family":"Yoshino","sequence":"first","affiliation":[{"name":"Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Okanishi","sequence":"additional","affiliation":[{"name":"Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Toyooka Public Hospital, 1094 Tobera, Toyooka 668-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nara Medical University Hospital, Kashihara 634-8522, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Umeda","sequence":"additional","affiliation":[{"name":"Department of Epileptology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Arai","sequence":"additional","affiliation":[{"name":"Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Maegaki","sequence":"additional","affiliation":[{"name":"Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18656","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Meyfroidt G, Baguley IJ, Menon DK. Paroxysmal sympathetic hyperactivity: the storm after acute brain injury. Lancet Neurol. 2017;16:721-9. PMID:28816118, DOI:10.1016\/S1474-4422(17)30259-4","DOI":"10.1016\/S1474-4422(17)30259-4"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Baguley IJ, Perkes IE, Fernandez-Ortega JF, Rabinstein AA, Dolce G, Hendricks HT; Consensus Working Group. Paroxysmal sympathetic hyperactivity after acquired brain injury: consensus on conceptual definition, nomenclature, and diagnostic criteria. J Neurotrauma. 2014;31:1515-20. PMID:24731076, DOI:10.1089\/neu.2013.3301","DOI":"10.1089\/neu.2013.3301"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Kirk KA, Shoykhet M, Jeong JH, Tyler-Kabara EC, Henderson MJ, Bell MJ, et al. Dysautonomia after pediatric brain injury. Dev Med Child Neurol. 2012;54:759-64. PMID:22712762, DOI:10.1111\/j.1469-8749.2012.04322.x","DOI":"10.1111\/j.1469-8749.2012.04322.x"},{"key":"4","unstructured":"4. Hotta A, Shimomura H, Nakayama K, Terasaki E, Tokunaga S, Mure C, et al. Atropine sulfate therapy for severe sialorrhea with paroxysmal sympathetic hyperactivity in a case of severe motor and intellectual disability. No To Hattatsu. 2021;53:39-43."},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Ichimiya Y, Kaku N, Sakai Y, Yamashita F, Matsuoka W, Muraoka M, et al. Transient dysautonomia in an acute phase of encephalopathy with biphasic seizures and late reduced diffusion. Brain Dev. 2017;39:621-4. PMID:28413125, DOI:10.1016\/j.braindev.2017.03.023","DOI":"10.1016\/j.braindev.2017.03.023"},{"key":"6","unstructured":"6. Yamamoto A, Ide S, Iwasaki Y, Kaga M, Arima M. [A case of prolonged paroxysmal sympathetic hyperactivity]. No To Hattatsu. 2016;48:127-31. PMID:27149743"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Johnston MV, Fatemi A, Wilson MA, Northington F. Treatment advances in neonatal neuroprotection and neurointensive care. Lancet Neurol. 2011;10:372-82. PMID:21435600, DOI:10.1016\/S1474-4422(11)70016-3","DOI":"10.1016\/S1474-4422(11)70016-3"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Baguley IJ, Heriseanu RE, Gurka JA, Nordenbo A, Cameron ID. Gabapentin in the management of dysautonomia following severe traumatic brain injury: a case series. J Neurol Neurosurg Psychiatry. 2006;78:539-41. PMID:17435191, DOI:10.1136\/jnnp.2006.096388","DOI":"10.1136\/jnnp.2006.096388"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Miyoshi T, Mizushima C, Noborio Y, Kimoto Y, Nakaharu Y, Shimamoto S. Efficacy of combination therapy with gabapentin and guanfacine for paroxysmal sympathetic hyperactivity following hypoxic encephalopathy: a case report. J Int Med Res. 2021;49:03000605211009721. PMID:33900871, DOI:10.1177\/03000605211009721","DOI":"10.1177\/03000605211009721"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Carozza RB, Mohanty D, Wolf MS, Martin EN, Anderson J, Pagano LM. Paroxysmal Sympathetic Hyperactivity: Development of a Pediatric Clinical Practice Guideline. Hosp Pediatr. 2023;13:e402-10. PMID:37953681, DOI:10.1542\/hpeds.2023-007261","DOI":"10.1542\/hpeds.2023-007261"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Perkes I, Baguley IJ, Nott MT, Menon DK. A review of paroxysmal sympathetic hyperactivity after acquired brain injury. Ann Neurol. 2010;68:126-35. PMID:20695005, DOI:10.1002\/ana.22066","DOI":"10.1002\/ana.22066"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Kumar S, Azim A, Singh S, Mishra P, Singh R, Ambasta S, et al. Role of gabapentin in traumatic brain injury: A prospective comparative study. Indian J Crit Care Med. 2024;28:120-5. PMID:38323259, DOI:10.5005\/jp-journals-10071-24634","DOI":"10.5005\/jp-journals-10071-24634"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Godo S, Irino S, Nakagawa A, Kawazoe Y, Fujita M, Kudo D, et al. Diagnosis and Management of Patients with Paroxysmal Sympathetic Hyperactivity following Acute Brain Injuries Using a Consensus-Based Diagnostic Tool: A Single Institutional Case Series. Tohoku J Exp Med. 2017;243:11-8. PMID:28890524, DOI:10.1620\/tjem.243.11","DOI":"10.1620\/tjem.243.11"},{"key":"14","unstructured":"14. Mori T, Kakimoto Y, Takenaka S, Shimoda K, Sato A, Oka A, et al. No To Hattatsu. 2020;52:264-6."}],"container-title":["Yonago Acta Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yam\/68\/3\/68_2025.08.006\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T04:43:51Z","timestamp":1755924231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yam\/68\/3\/68_2025.08.006\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.33160\/yam.2025.08.006","relation":{},"ISSN":["1346-8049"],"issn-type":[{"type":"electronic","value":"1346-8049"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2025.08.006"}}